3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium

C27H14IrNS- — CID 59622151

IUPAC3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium
SMILES[Ir].[c-]1cc2c(cc1-c1cc3c4c(cccc4n1)-c1ccccc1-3)sc1ccccc12
InChIInChI=1S/C27H14NS.Ir/c1-2-7-18-17(6-1)21-9-5-10-23-27(21)22(18)15-24(28-23)16-12-13-20-19-8-3-4-11-25(19)29-26(20)14-16;/h1-11,13-15H;/q-1;
InChIKeyFDGRQHZGSBCXHE-UHFFFAOYSA-N
MW576.70 g/mol
LogP7.71
Rot. Bonds1

About 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium

3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium (PubChem CID 59622151) has the molecular formula C27H14IrNS- and a molecular weight of 576.70 g/mol. Its IUPAC name is 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium.

Molecular Properties

Compound Name3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium
PubChem CID59622151
Molecular FormulaC27H14IrNS-
Molecular Weight576.70 g/mol
Exact Mass577.05
IUPAC Name3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium
SMILES[Ir].[c-]1cc2c(cc1-c1cc3c4c(cccc4n1)-c1ccccc1-3)sc1ccccc12
InChIInChI=1S/C27H14NS.Ir/c1-2-7-18-17(6-1)21-9-5-10-23-27(21)22(18)15-24(28-23)16-12-13-20-19-8-3-4-11-25(19)29-26(20)14-16;/h1-11,13-15H;/q-1;
InChIKeyFDGRQHZGSBCXHE-UHFFFAOYSA-N
XLogP7.71
TPSA12.89 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds1
Heavy Atoms30
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500576.70
LogP ≤ 57.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium?
The IUPAC name of 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium (CID 59622151) is 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium.
What is the SMILES notation for 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium?
The canonical SMILES for 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium is [Ir].[c-]1cc2c(cc1-c1cc3c4c(cccc4n1)-c1ccccc1-3)sc1ccccc12.
What is the InChIKey of 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium?
The InChIKey is FDGRQHZGSBCXHE-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H14NS.Ir/c1-2-7-18-17(6-1)21-9-5-10-23-27(21)22(18)15-24(28-23)16-12-13-20-19-8-3-4-11-25(19)29-26(20)14-16;/h1-11,13-15H;/q-1;.
What are the key properties of 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium?
3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium has a molecular weight of 576.70 g/mol, XLogP of 7.71, 1 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2H-dibenzothiophen-2-id-3-yl)-4-azatetracyclo[7.6.1.05,16.010,15]hexadeca-1,3,5,7,9(16),10,12,14-octaene;iridium is sourced from PubChem (CID 59622151), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).